BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2483548)

  • 1. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
    Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.
    Sakurada T; Yamada T; Tan-no K; Manome Y; Sakurada S; Kisara K; Ohba M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):205-10. PubMed ID: 1717679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
    Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
    Post C; Folkers K
    Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
    Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
    Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
    Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
    Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice.
    Sakurada T; Katsumata K; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1993 Sep; 242(1):47-52. PubMed ID: 7693495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
    Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
    Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
    Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural characterization of substance P-induced nociceptive response in mice.
    Takahasi K; Sakurada T; Sakurada S; Kuwahara H; Yonezawa A; Ando R; Kisara K
    Neuropharmacology; 1987 Sep; 26(9):1289-93. PubMed ID: 2444899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
    Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
    Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
    Vaught JL; Scott R
    Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of tachykinin analogues on ganglion cell activity in cyprinid fish retina.
    Downing JE; Djamgoź MB
    Neuropeptides; 1993 Feb; 24(2):109-16. PubMed ID: 7681551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural assessment as substance P antagonists in mice.
    Sakurada T; Kuwahara H; Sakurada S; Kisara K; Ohba M; Munekata E
    Neuropeptides; 1987 Apr; 9(3):197-206. PubMed ID: 2439938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural responses induced by intrathecal injection of 5-hydroxytryptamine in mice are inhibited by a substance P antagonist, D-Pro2, D-Trp7,9-substance P.
    Fasmer OB; Post C
    Neuropharmacology; 1983 Dec; 22(12A):1397-400. PubMed ID: 6198594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
    Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
    Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.